Loading…
Lobbying Income
$320K
Filings
40
Unique Clients
1
Active Period
2013–2022
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Repurposing Assets to Increase Long-term Water Availability and Yield Act
2020 · third_quarter · Client: CAMERON COMPANIES
Monitored HR 1600, "HEROES Act." Monitored the Emergency Appropriations for Coronavirus Health Response and Agency Operations and the CARES "Corornavirus Aid, Relief and Economic Security Act" and interim supplemental relief legislation. Monitored the Medicare accelerated payment program provisions.
Client expense: — · Firm income: $10,000
Matched citations: HR 1600
Repurposing Assets to Increase Long-term Water Availability and Yield Act
2020 · second_quarter · Client: CAMERON COMPANIES
Monitored HR 1600, "HEROES Act." Monitored the Emergency Appropriations for Coronavirus Health Response and Agency Operations and the CARES "Corornavirus Aid, Relief and Economic Security Act" and interim supplemental relief legislation. Monitored the Medicare accelerated payment program provisions.
Client expense: — · Firm income: $10,000
Matched citations: HR 1600
Consumer Protections Against Surprise Medical Bills Act of 2020
2020 · first_quarter · Client: CAMERON COMPANIES
Monitored HR 5826, "Consumer Protections Against Surprise Medical Bills Act of 2020." Monitored the Emergency Appropriations for Coronavirus Health Response and Agency Operations and the CARES "Corornavirus Aid, Relief and Economic Security Act."
Client expense: — · Firm income: $10,000
Matched citations: HR 5826
Lymphedema Treatment Act of 2019
2019 · fourth_quarter · Client: CAMERON COMPANIES
Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies, such as CAR-T. Reviewed HR 1948, Lymphedema Treatment Act and HR 3235, Access to Genetic Counselor Services Act for potential support.
Client expense: — · Firm income: $10,000
Matched citations: HR 1948
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Client: CAMERON COMPANIES
Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies, such as CAR-T. Reviewed HR 1948, Lymphedema Treatment Act and HR 3235, Access to Genetic Counselor Services Act for potential support.
Client expense: — · Firm income: $10,000
Matched citations: HR 3
Access to Genetic Counselor Services Act of 2019
2019 · fourth_quarter · Client: CAMERON COMPANIES
Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies, such as CAR-T. Reviewed HR 1948, Lymphedema Treatment Act and HR 3235, Access to Genetic Counselor Services Act for potential support.
Client expense: — · Firm income: $10,000
Matched citations: HR 3235
Helping Hospitals Improve Patient Care Act of 2016
2016 · fourth_quarter · Client: CAMERON COMPANIES
21st Century Cures Act to include the language of Section 202 of H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016 to exempt dedicated cancer centers from the site-neutral payment changes enacted by Section 603 of the Bipartisan Budget Act of 2015.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 5273
Helping Hospitals Improve Patient Care Act of 2016
2016 · third_quarter · Client: CAMERON COMPANIES
Section 202 of H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016 to exempt dedicated cancer centers from the site-neutral payment changes enacted by Section 603 of the Bipartisan Budget Act of 2015.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 5273
Helping Hospitals Improve Patient Care Act of 2016
2016 · second_quarter · Client: CAMERON COMPANIES
Section 202 of H.R. 5273, the Helping Hospitals Improve Patient Care Act of 2016 to exempt dedicated cancer centers from the site-neutral payment changes enacted by Section 603 of the Bipartisan Budget Act of 2015.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 5273
Medicare Patient Access to Cancer Treatment Act of 2013
2013 · third_quarter · Client: CAMERON COMPANIES
HR 2869, the proposed Medicare Patient Access to Cancer Treatment Act of 2013, that would equalize Medicare reimbursements for cancer services between hospital outpatient departments and physician offices.
Client expense: — · Firm income: $10,000
Matched citations: HR 2869
Source: Senate LDA